Selective cytotoxic activity of prodigiosin@halloysite nanoformulation

HIGHLIGHTS

• who: Ivan Guryanov from the Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, Russia, Dipartimento Fisica Chimica have published the research work: Selective Cytotoxic Activity of Prodigiosin, in the Journal: (JOURNAL)
• what: The authors report for the first time fabrication of prodigiosin-based nanoformulation (p-HNTs) and its effects on viability of malignant and non-malignant cells. with metastases suppression (Zhang et_al, 2005).
• how: Hyperspectral data were collected with ENVI software version 4.8 (Harris Geospatial Solutions) (Akhatova et_al 2018). The detailed characterization of HNTs results are shown in Figure 1 . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.